These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30865722)

  • 21. Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.
    Palombi L; Marazzi MC; Guidotti G; Germano P; Buonomo E; Scarcella P; Doro Altan A; Zimba Ida V; San Lio MM; De Luca A;
    Clin Infect Dis; 2009 Jan; 48(1):115-122. PubMed ID: 20380075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.
    Miller V; Mocroft A; Reiss P; Katlama C; Papadopoulos AI; Katzenstein T; van Lunzen J; Antunes F; Phillips AN; Lundgren JD
    Ann Intern Med; 1999 Apr; 130(7):570-7. PubMed ID: 10189326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care-a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999-2013.
    Zeitlmann N; Gunsenheimer-Bartmeyer B; Santos-Hövener C; Kollan C; An der Heiden M;
    BMC Infect Dis; 2016 Dec; 16(1):739. PubMed ID: 27927190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania.
    Stete K; Glass TR; van Dam GJ; Ntamatungiro A; Letang E; de Dood CJ; Corstjens PLAM; Ndege R; Mapesi H; Kern WV; Hatz C; Weisser M; Utzinger J; Müller MC
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006844. PubMed ID: 30332404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
    AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicoepidemiological characteristics of HIV-infected immigrants attended at a tropical medicine referral unit.
    Pérez-Molina JA; López-Vélez R; Navarro M; Pérez-Elías MJ; Moreno S
    J Travel Med; 2009; 16(4):248-52. PubMed ID: 19674264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
    Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
    BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
    Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
    Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012.
    Collin A; Le Marec F; Vandenhende MA; Lazaro E; Duffau P; Cazanave C; Gérard Y; Dabis F; Bruyand M; Bonnet F;
    PLoS One; 2016; 11(4):e0152970. PubMed ID: 27050752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttraumatic Stress Disorder as a Significant Correlate of Voluntary Antiretroviral Treatment Interruption in Adult HIV-Infected Patients Followed up in French Hospitals: Data From the ANRS-VESPA2 National Survey.
    Roux P; Marcellin F; Ndiaye K; Suzan-Monti M; Mayet A; Duracinsky M; Briand-Madrid L; Maradan G; Mora M; Préau M; Verger P; Carrieri P; Dray-Spira R; Spire B;
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29659208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for interruption in treatment among HIV-infected adolescence attending health care and treatment clinics in Tanzania.
    Mtisi EL; Mushy SE; Mkawe SG; Ndjovu A; Mboggo E; Mlay BS; Ngalesoni F; Muya A
    AIDS Res Ther; 2023 Mar; 20(1):19. PubMed ID: 36998051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam.
    Tran DA; Shakeshaft A; Ngo AD; Mallitt KA; Wilson D; Doran C; Zhang L
    HIV Clin Trials; 2013; 14(1):21-33. PubMed ID: 23372112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
    Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
    AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.
    Assoumou L; Weiss L; Piketty C; Burgard M; Melard A; Girard PM; Rouzioux C; Costagliola D;
    AIDS; 2015 Sep; 29(15):2003-7. PubMed ID: 26355572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
    Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
    Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
    Badje A; Moh R; Gabillard D; Guéhi C; Kabran M; Ntakpé JB; Carrou JL; Kouame GM; Ouattara E; Messou E; Anzian A; Minga A; Gnokoro J; Gouesse P; Emieme A; Toni TD; Rabe C; Sidibé B; Nzunetu G; Dohoun L; Yao A; Kamagate S; Amon S; Kouame AB; Koua A; Kouamé E; Daligou M; Hawerlander D; Ackoundzé S; Koule S; Séri J; Ani A; Dembélé F; Koné F; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatunde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Karcher S; Rouzioux C; Kouame A; Assi R; Bakayoko A; Domoua SK; Deschamps N; Aka K; N'Dri-Yoman T; Salamon R; Journot V; Ahibo H; Ouassa T; Menan H; Inwoley A; Danel C; Eholié SP; Anglaret X;
    Lancet Glob Health; 2017 Nov; 5(11):e1080-e1089. PubMed ID: 29025631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.
    Thierfelder C; Weber R; Elzi L; Furrer H; Cavassini M; Calmy A; Bernasconi E; Gutmann C; Ledergerber B;
    HIV Med; 2012 Feb; 13(2):118-26. PubMed ID: 22107170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.